HSBC Holdings plc set a €52.00 ($60.47) price objective on Carl Zeiss Meditec AG (ETR:AFX) in a research report report published on Friday. The brokerage currently has a buy rating on the stock.

A number of other brokerages also recently weighed in on AFX. Berenberg Bank set a €48.00 ($55.81) target price on shares of Carl Zeiss Meditec AG and gave the company a buy rating in a research note on Tuesday, October 17th. DZ Bank AG reaffirmed a sell rating on shares of Carl Zeiss Meditec AG in a research note on Thursday, October 19th. Deutsche Bank AG set a €40.00 ($46.51) target price on shares of Carl Zeiss Meditec AG and gave the company a neutral rating in a research note on Tuesday, August 8th. Commerzbank Ag set a €42.00 ($48.84) target price on shares of Carl Zeiss Meditec AG and gave the company a neutral rating in a research note on Tuesday, August 8th. Finally, Kepler Capital Markets set a €48.50 ($56.40) price target on shares of Carl Zeiss Meditec AG and gave the stock a buy rating in a research note on Monday, August 7th. One research analyst has rated the stock with a sell rating, three have given a hold rating and four have issued a buy rating to the company. The stock has a consensus rating of Hold and an average target price of €46.64 ($54.24).

Shares of Carl Zeiss Meditec AG (AFX) opened at €48.56 ($56.46) on Friday. Carl Zeiss Meditec AG has a one year low of €30.80 ($35.81) and a one year high of €48.61 ($56.52).

ILLEGAL ACTIVITY WARNING: This article was reported by Daily Political and is the property of of Daily Political. If you are viewing this article on another publication, it was stolen and republished in violation of US and international copyright legislation. The legal version of this article can be viewed at https://www.dailypolitical.com/2017/11/14/carl-zeiss-meditec-ag-afx-pt-set-at-52-00-by-hsbc-holdings-plc.html.

About Carl Zeiss Meditec AG

Carl Zeiss Meditec AG operates as a medical technology company worldwide. It operates through Ophthalmic Devices and Microsurgery segments. The Ophthalmic Devices segment offers optical biometers, ophthalmic microscopes, phacoemulsification/vitrectomy devices, intraocular lenses, and ophthalmic viscoelastic products for the diagnosis and treatment of ophthalmic diseases in the field of cataract and retinal surgery.

Analyst Recommendations for Carl Zeiss Meditec AG (ETR:AFX)

Receive News & Ratings for Carl Zeiss Meditec AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec AG and related companies with MarketBeat.com's FREE daily email newsletter.